ixabepilone + vinflunine

**Ixabepilone + vinflunine** is a combination of two anti-mitotic chemotherapeutic agents, both small molecules that target and disrupt microtubule dynamics but via distinct mechanisms, leading to arrested cell division and apoptosis. - **Ixabepilone** is an epothilone-class agent that binds and stabilizes beta-tubulin subunits, suppressing microtubule dynamic instability, thereby blocking entry into mitosis and inducing cell death. It is effective in various tumor xenografts and shows activity in taxane-resistant malignancies[4][5][7]. - **Vinflunine** is a third-generation vinca alkaloid that binds to beta-tubulin at or near the vinca binding site, inhibiting microtubule assembly, suppressing treadmilling, and causing mitotic arrest and apoptosis[2][3][6]. This combination is investigational and studied primarily for advanced/metastatic cancers (e.g., breast or urothelial); both drugs individually demonstrate synergistic cytotoxicity with other agents but published studies of this exact pairing are limited.

Brand names

Ixempra

Other names

ixabepilone + vinflunine